PS

Petrus Johannes Louis Spee

NA Novo Nordisk A/S: 8 patents #172 of 1,775Top 10%
IP Innate Pharma: 3 patents #33 of 85Top 40%
CN CNRS: 2 patents #1,756 of 11,908Top 15%
NA Novo Nordisk A/S—Novo Alle: 1 patents #12 of 42Top 30%
UG University Of Genoa: 1 patents #22 of 32Top 70%
Overall (All Time): #460,854 of 4,157,543Top 15%
11
Patents All Time

Issued Patents All Time

Showing 1–11 of 11 patents

Patent #TitleCo-InventorsDate
9708403 KIR-binding agents and methods of use thereof Søren Berg Padkær, Peter Andreas Nicolai Reumert Wagtmann, Stefan Zahn, Kristian Kjærgaard, Anders Svensson 2017-07-18
9683041 Anti-NKG2A antibodies and uses thereof Soeren Berg Padkaer 2017-06-20
9447185 Compositions and methods for treating proliferative disorders Francois Romagne, Alessandro Moretta, Mathieu Blery, Ulrik Morch 2016-09-20
9422368 Humanized anti-human NKG2A monoclonal antibody Jianhe Chen, Soren Padkjaer, Jing Su, Jinchao ZHANG, Jiujiu Yu 2016-08-23
9376496 LLT-1 antibodies with new functional properties Peter Andreas Nicolai Reumert Wagtmann, Stefan Zahn, Elisabeth Douglas Galsgaard, Birgitte Friedrichsen, Véronique Braud 2016-06-28
9127052 LLT-1 antibodies with new functional properties Peter Andreas Nicolai Reumert Wagtmann, Stefan Zahn, Elisabeth Douglas Galsgaard, Birgitte Friedrichsen, Véronique Braud 2015-09-08
8901283 Anti-NKG2A antibodies and uses thereof Soeren Berg Padkaer 2014-12-02
8796427 Humanized anti-human NKG2A monoclonal antibody Jianhe Chen, Søren Berg Padkjær, Jing Su, Jinchao ZHANG, Jiujiu Yu 2014-08-05
8614307 Nucleic acids encoding human anti-kir antibodies Alessandro Moretta, Mariella Della Chiesa, Pascale Andre, Laurant Gauthier, Francois Romagne +8 more 2013-12-24
8206709 Anti-NKG2A antibodies and uses thereof Søren Berg Padkær 2012-06-26
7932055 Soluble heterodimeric CD94/NKG2 receptors fusion proteins Søren Berg Padkær, Birgitte Friedrichsen, Inga Sig Nielsen Nørby 2011-04-26